| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Fred Telling is Director at OGEN. Fred Telling's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13K at current prices.
Historically, Fred Telling's trades have earned a middling insider score of 50/100 across 11 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -48.1%.
Net of sales, the OGEN filings show accumulation of 1,675,795 shares.
Fred Telling has 28 Form 4 filings on record from March 2015 to December 2025, all as Director at Oragenics (OGEN), 2015–2025.
The 39 reported transactions were 15 open-market purchases, 14 option or other derivative awards, 5 stock awards and 3 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 7 purchases worth about $668K and 3 sales worth about $14K.
The largest open-market purchase was 969,180 shares of OGEN at an average $0.52 on June 30, 2016, about $500K.
The largest open-market sale was 3,500 shares of OGEN at an average $3.57 on November 30, 2023, about $12K. Twelve months later OGEN was down 91%.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | OGEN Oragenics Inc | Director | Sell | 210 | $0.94 | $198.37 | -0.6% | +5.0% | - | |
| Dec 6, 2024 | OGEN Oragenics Inc | Director | Sell | 3,597 | $0.36 | $1,294.92 | -9.4% | -25.0% | -92.0% | |
| Nov 30, 2023 | OGEN Oragenics Inc | Director | Sell | 3,500 | $3.57 | $12,488.35 | -8.4% | -60.3% | -91.1% | |
| Jun 17, 2022 | OGEN Oragenics Inc | Director | Buy | 10,084 | $0.29 | $2,884.02 | +1.0% | -10.9% | -84.7% | |
| May 24, 2022 | OGEN Oragenics Inc | Director | Buy | 82,173 | $0.29 | $23,779.98 | +9.0% | +29.5% | -82.0% | |
| May 20, 2022 | OGEN Oragenics Inc | Director | Buy | 65,718 | $0.28 | $18,637.62 | +7.7% | +33.9% | -82.4% | |
| May 19, 2022 | OGEN Oragenics Inc | Director | Buy | 72,109 | $0.28 | $19,939.53 | +9.2% | +36.0% | -82.2% | |
| Mar 31, 2022 | OGEN Oragenics Inc | Director | Buy | 183,838 | $0.36 | $66,053.42 | +30.8% | +3.3% | -84.1% | |
| Nov 24, 2020 | OGEN Oragenics Inc | - | Buy | 100,000 | $0.37 | $37,000.00 | +29.5% | - | - | |
| Mar 25, 2019 | OGEN Oragenics Inc | Director | Buy | 100,000 | $0.00 | - | +41.7% | - | - |